RxDoctor Payments Data

Scott Pritzlaff, MD

Anesthesiology · Redwood City, CANPI 1912061805

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $112,416 of the $165,131 with a category attached, or 68.1%. SPR Therapeutics, Inc accounts for 77.3% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $61,105, more than ten times the $135 reported in 2019. Among anesthesiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$165,131in general payments, 2019–2025

Across 256 payments — averaging $645.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SPR Therapeutics, Inc$128K
  • Nalu Medical, Inc.$20K
  • Bioventus LLC$8K
  • Medtronic$5K
  • Abbott$2K
  • Boston Scientific$2K
  • plus $1K from 9 others
$6,615in research payments, 2019–2025

Across 3 payments — averaging $2205.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$7K

What the payments were for

  • Consulting fees$112,41668%
  • Speaking & faculty fees$7,5435%
  • Travel & lodging$27,66317%
  • Food & beverage$17,50911%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$165,131 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.

See all anesthesiology providers in California

Medicare billing

Part B allowed, 2024
$116,810
Medicare patients
318
Services billed
1,333

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl37$673
Gabapentin24$292

Paid to pharmacies, not to this prescriber.

Other anesthesiology in Redwood City

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →